• The 2022 symposium on dementia and brain aging in low- and middle-income countries: Highlights on research, diagnosis, care, and impact 

  Kalaria, Raj; Maestre, Gladys; Mahinrad, Simin; Acosta, Daisy M.; Akinyemi, Rufus Olusola; Alladi, Suvarna; Allegri, Ricardo Francisco; Arshad, Faheem; Babalola, David Oluwasayo; Baiyewu, Olusegun; Bak, Thomas H.; Bellaj, Tarek; Brodie-Mends, David K.; Carrillo, Maria C.; Celestin, Kaputu-Kalala-Malu; Damasceno, Albertino; de Silva, Ranil Karunamuni; de Silva, Rohan; Djibuti, Mamuka; Dreyer, Anna Jane (John Wiley & Sons, Ltd., 2024-05-02)

  Two of every three persons living with dementia reside in low- and middle-income countries (LMICs). The projected increase in global dementia rates is expected to affect LMICs disproportionately. However, the majority of ...
• Human chorionic gonadotropin regulates cytokine production by lymphocytes from patients with multiple sclerosis 

  Juriol, Lorena; Valeff, Natalín; Dibo, Marcos; Ventimiglia, María Silvia; Correale, Jorge; Jensen, Federico (Elsevier/North-Holland Biomedical Press, 2024-06-12)

  Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system (CNS) that primarily affects young adults, predominantly females. This was partially attributed to sex differences in ...
• Generating real-world evidence in Alzheimer's disease: Considerations for establishing a core dataset 

  Galvin, James E.; Cummings, Jeffrey L.; Levitchi Benea, Mihaela; de Moor, Carl; Allegri, Ricardo Francisco; Atri, Alireza; Chertkow, Howard; Paquet, Claire; Porter, Verna R.; Ritchie, Craig W.; Sikkes, Sikkes A.M.; Smith, Michael R.; Grassi, Christina Marsica; Rubino, Ivana (John Wiley & Sons, Ltd., 2024-05-06)

  Ongoing assessment of patients with Alzheimer's disease (AD) in postapproval studies is important for mapping disease progression and evaluating real-world treatment effectiveness and safety. However, interpreting outcomes ...
• Incidencia, circunstancias y consecuencias de caídas en sujetos con accidente cerebrovascular: un año de seguimiento 

  Del Castillo, Marcelo Ernesto; Mosteiro, María Agustina; Navarro, Julieta; Rivas, María Elisa; Gianella, Matías Gabriel; Ahumada, Martina H. (Elsevier, 2023-07-01)

  Introducción Luego del accidente cerebrovascular (ACV), una de las complicaciones más frecuentes son las caídas, impactando negativamente en la rehabilitación. Objetivos Estudiar la incidencia, las circunstancias y ...
• The impact of reward and punishment sensitivity on memory and executive performance in individuals with amnestic mild cognitive impairment 

  Corvalán, Nicolás; Crivelli, Lucía; Allegri, Ricardo Francisco; Pedreira, Maria E.; Fernández, Rodrigo S. (Elsevier/North-Holland Biomedical Pres, 2024-06-10)

  Amnestic mild cognitive impairment (aMCI) is defined by memory impairment but executive function (EF) deficits could be also a common feature. This study examined the underlying neurocognitive processes associated with ...
• Treatment strategies and responses for attacks of neuromyelitis optica spectrum disorder: A real-world retrospective cohort study 

  Carnero Contentti, Edgar; Lopez, Pablo A.; Pettinicchi, Juan Pablo; Miguez, Jimena; Patrucco, Liliana; Cristiano, Edgardo; Liwacki, Susana; Tkachuk, Verónica; Balbuena, María Eugenia; Vrech, Carlos; Deri, Norma; Correale, Jorge; Marrodán, Mariano; Ysrraelit, María Célica; Leguizamón, Felisa; Luetic, Geraldine; Tavolini, Darío; Mainella, Carolina; Zanga, Gisela; Burgos, Marcos; Hryb, Javier; Barboza, Andrés; Lazaro, Luciana; Alonso, Ricardo; Fernández Liguori, Nora; Nadur, Débora; Alonso Serena, Marina; Caride, Alejandro; Rojas, Juan I. (Elsevier, 2024-07-15)

  We aimed to assess the treatment strategies utilized in patients with neuromyelitis optica spectrum disorder (NMOSD) experiencing relapses, including their frequency, types, and response after 6 months based on the Expanded ...
• Qué es un banco de cerebros 

  Sevlever, Gustavo Emilio (Polemos, 2023)

  Capítulo 17 de "Enfermedad de Alzheimer y otras demencias: manual para la familia"
• Difundir la prevención a la comunidad: llegar antes 

  Canevaro, Lilia; Bagnati, Pablo M. (Polemos, 2023)

  Capítulo 14 de "Enfermedad de Alzheimer y otras demencias: manual para la familia"
• Tratamientos en demencias 

  Bagnati, Pablo M.; Kremer, Janus; Waisman Campos, Marcela (Polemos, 2023)

  Capítulo 12 de "Enfermedad de Alzheimer y otras demencias: manual para la familia"
• Conducción de automóviles y demencia 

  Bagnati, Pablo M.; Sambade, Silvia (Polemos, 2023)

  Capítulo 11 de "Enfermedad de Alzheimer y otras demencias: manual para la familia"
• ¿Por qué muere un paciente con Alzheimer? Complicaciones médicas y neurológicas en la progresión de la demencia 

  Cohen, Gabriela; Campos, Jorge (Polemos, 2023)

  Capítulo 10 de "Enfermedad de Alzheimer y otras demencias: manual para la familia"
• ¿Qué riesgo tengo de heredar la enfermedad de Alzheimer? Genética y demencias 

  Chrem Méndez, Patricio Alexis; Surace, Ezequiel Ignacio (Polemos, 2023)

  Capítulo 7 de "Enfermedad de Alzheimer y otras demencias: manual para la familia"
• ¿Qué es la demencia? 

  Bagnati, Pablo M. (Polemos, 2023)

  Introducción de "Enfermedad de Alzheimer y otras demencias: manual para la familia"
• Trastornos de conducta en la enfermedad de Alzheimer 

  Magrath Guimet, Nahuel; Herrera, Julio José; Fernández, María Laura (Polemos, 2023)

  Capítulo 4 de "Enfermedad de Alzheimer y otras demencias: manual para la familia"
• Olvidos: ¿normal envejecimiento o síntomas de enfermedad? 

  Castro, Diego M.; Allegri, Ricardo Francisco (Polemos, 2023)

  Capítulo 2 de "Enfermedad de Alzheimer y otras demencias: manual para la familia"
• Enfermedad de Alzheimer y otras demencias : manual para la familia 

  Bagnati, Pablo M. (Polemos, 2023)

  Resumen no disponible
• Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina 

  Rojas, Juan Ignacio; Alonso, Ricardo; Luetic, Geraldine G.; Patrucco, Liliana; Casas, Magdalena; Silva, Berenice Anabel; Miguez, Jimena; Deri, Norma; Vrech, Carlos; Liwacki, Susana; Piedrabuena, Raúl; Silva, Emanuel; Tkachuk, Verónica A.; Burgos, Marcos; Tavolini, Darío; Zanga, Gisela; Alvez Pinheiro, Amelia; Hryb, Javier Pablo; Leguizamon, Felisa; Knorre, Eduardo; López, Pablo Adrián; Martínez, Alejandra Diana; Carrá, Adriana; Alonso Serena, Marina; Cristiano, Edgardo; Correale, Jorge; Garcea, Orlando; Fernández Liguori, Nora; Carnero Contentti, Edgar (Lippincott Williams & Wilkins, 2024-05-23)

  Objective: The aim was to evaluate patient profiles, effectiveness and safety of cladribine (CLAD) in patients with relapsing-remitting multiple sclerosis in Argentina. Methods: This was a substudy included in RelevarEM ...
• Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's disease. 

  Iaccarino, Leonardo; Llibre Guerra, Jorge J.; McDade, Eric; Edwards, Lauren; Gordon, Brian A.; Benzinger, Tammie L.S.; Hassenstab, Jason; Kramer, Joel H.; Li, Yan; Miller, Bruce L.; Miller, Zachary; Morris, John C.; Mundada, Nidhi; Perrin, Richard J.; Rosen, Howard J.; Soleimani Meigooni, David; Strom, Amelia; Tsoy, Elena; Wang, Guoqiao; Xiong, Chengjie; Allegri, Ricardo Francisco; Chrem Méndez, Patricio Alexis; Vázquez, Silvia (Oxford University Press, 2024-05-03)

  Approximately 5% of Alzheimer's disease patients develop symptoms before age 65 (early-onset Alzheimer's disease), with either sporadic (sporadic early-onset Alzheimer's disease) or dominantly inherited (dominantly inherited ...
• Efficacy and safety of erdafitinib in pediatric patients with advanced solid tumors and FGFR alterations in the phase 2 RAGNAR trial 

  Olaf Witt, Sameer Farouk Sait; Diez, Blanca; Cardoso, Agustín; Reardon, David A.; Welsh, Liam; Shih, Kent C.; Baldini, Capucine; Massard, Christophe; Loriot, Yohann; Pant, Shubham; Sweiti, Hussein; Thomas, Shibu; Hammond, Constance; Najmi, Saltanat; Triantos, Spyros; Crow, Lauren; Geoerger, Birgit (American Society of Clinical Oncology, 2024-06)

  Background: Erdafitinib is an oral selective pan-fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor approved in the US for adult patients (pts) with locally advanced or metastatic urothelial carcinoma with ...
• Clinical efficacy of a next-generation sequencing (NGS) and immunohistochemistry (IHC) panel in patients with advanced cancer in Argentina. 

  Cantarella, Florencia; Mendoza Bertelli, Andrea; Girotti, Romina; Marino, Ana Clara; Brest, Esteban; Dibarbora, Delfina; Mahmoud, Yamil; Veigas, Florencia; Enrico, Diego Hernan; Tsou, Florencia; Lacava, Juan A.; Piazzoni, Luciano; Riso, Aldo Alejandro; Martinengo, Gastón L.; Rodriguez, Andrés; Beguelin, Zenon; Cerrato, Sebastián; Jerez, Ignacio; Salanova, Rubén (American Society of Clinical Oncology, 2024-05-29)

  Background: The analysis of somatic genomic alterations, evaluation of DNA mismatch repair (MMR) proteins, and examination of PD-L1 expression in tumor biopsies are crucial for prognosis and informed therapeutic decisions. ...

Más